Resources

Past Presentation

Repurposing GLP-1 Receptor Agonists for Substance Use Disorders | August 18, 2026

Date of Presentation: August 18, 2026

Type: Past Presentation  

Audience: Clinical  

Program: Advancing Pharmacist Roles in Substance Use Disorder Treatment and Recovery Teams  

Keywords: #alcohol  #aud  #disorder  #glp  #GLP-1  #nih  #substance  #SUD  #use  #weight  

In this presentation, Dr. Weiss reviews the neurobiological rationale and emerging clinical evidence supporting the use of glucagon-like peptide-1 (GLP-1) receptor agonists for alcohol and other substance use disorders (SUDs). Dr. Weiss also discusses the efficacy, safety, and potential role of these agents in comprehensive, person-centered treatment of SUDs.

Recording:

Presented by:

Stephanie Weiss, MD, PhD
Staff Research Physician | National Institutes of Health

Resources Provided:

Date added: August 7, 2026